Funding event
The round itself, as filedInferred stageSeed
Sold of offered$5.5M of Indefinite
Filed2026-09-16
Days since filing17
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
- Date of first sale
- 2026-09-02
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Cortney KnollExecutive Officer · Director
- Martin Roche, M.D.Director
- Rony AbovitzDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged—1 month since first sale
Prior raiseNot flaggedRaised 55% of its prior round, 2 months on$10.0M prior raise, filed 2026-06-23
AmendedNot flaggedD/A on 2026-06-23Amount offered unchanged or not stated
Open roles
On the employer's own careers page · checked 2026-09-214
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
- Senior Data Platform Engineer, Clinical AISEP 21West Palm Beach / Fort Lauderdale, Florida · Full-Time, On-Site · open 13 days
- Research Scientist, Surgical Computer VisionSEP 21West Palm Beach / Fort Lauderdale, Florida · Full-Time, On-Site · open 13 days
- IT SpecialistSEP 21Ft. Lauderdale, FL · open 13 days
- Associate Product ManagerSEP 21Remote, Eastern/Central time zone preferred · open 13 days
All filings
Every filing for this company, newest first, amendments includedAlso raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-02, against 71 in the 28 days before.